Market Tracker

01/16 7:32am ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

8.97
Delayed Data
As of Jan 13
 -0.02 / -0.22%
Today’s Change
6.10
Today|||52-Week Range
13.80
+6.53%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close8.99
Today’s open8.95
Day’s range8.86 - 9.37
Volume41,715
Average volume (3 months)51,604
Market cap$166.2M
Dividend yield43.68%
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-450.00%
Earnings growth (this year)-65.91%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.05+0.51%
CTSOCytosorbents Corp-0.15-2.52%
CDXCChromadex Corp+0.03+1.01%
LFVNLifeVantage Corp+0.14+1.85%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$23.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Director, Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts